Introduction
The heart is a muscle pump that weighs approximately 300 grams and measures the size of a human fist, composed primarily of the left and right atria.1
What is a left bundle branch block (LBBB)?
When the normal electrical impulse that controls and coordinates your heartbeat is blocked, delayed, or severely disrupted during its passage through the heart's conduction system, it results in a left bundle branch block (LBBB). An irregular or aberrant heart rhythm results from the ventricles, especially the left ventricle, not receiving the impulse in the typical, timely manner due to this restriction or change in the transmission pathway. An ECG showing a left bundle branch block is often an indication that the conduction abnormalities may be caused by an underlying anatomical or functional heart issue.2 Clinically speaking, LBBB is classified as an intraventricular conduction delay and is distinguished by the left ventricle's delayed activation relative to the right. The electrical activity that starts ventricular contraction and the subsequent pumping of blood throughout the body is represented by a dilated or expanded QRS complex (≥120 ms), which is the manifestation of this electrical disruption. The characteristic diagnostic features for LBBB are the enlarged QRS complex as well as clear and identifiable ECG changes.3 A left bundle branch block is more likely to occur as people age; although its frequency is less than 1% in those under 50, it grows dramatically as people age, being much more common by the age of 80 and older.4
Pathophysiology
Any blockage in this channel, as observed in left bundle branch block (LBBB), interferes with the normal conduction process of impulses that are sent to the left ventricle (LV) via the left bundle branch. Asynchronous ventricular contraction, which results from this disturbance, severely reduces heart efficiency. The main ways that LBBB causes left ventricular dysfunction are through the delay and modification of LV contraction. Ventricular remodelling, increasing dilatation, and eventually a decrease in the ejection fraction are the results of this electrical and mechanical discordance over time. In addition to increasing myocardial wall stress, the resulting electromechanical delay predisposes the heart to LBBB-induced cardiomyopathy. Crucially, however, some patients maintain their clinical stability in spite of the conduction abnormalities, therefore, the presence of LBBB does not always translate into symptomatic heart failure. However, LBBB can worsen the prognosis and speed up functional deterioration in those who are vulnerable or have structural heart disease already.5
Causes
Heart injury frequently leads to left bundle branch block. The following conditions can result in LBBB:
- Myocardial infarction, or heart attack
- Coronary artery disease or heart disease
- Heart failure, infection of the heart (myocarditis) or heart valve disorders
- Hypertension, or elevated blood pressure
- Heart muscle weakness or stiffness (cardiomyopathy)
- Birth malformations of the heart
Sometimes the source of a left bundle branch block is unknown. It can happen to individuals without any underlying medical issues whose hearts otherwise beat regularly.2
Symptoms
There may be no symptoms associated with the left bundle branch block. When signs of this illness do appear, they could include:
- Fainting (syncope)
- Presyncope is the feeling that you are about to faint
- Slow heart rate2
Diagnosis
An electrocardiogram (ECG or EKG), a common non-invasive test performed by medical practitioners to monitor the electrical activity of the heart, is typically used to diagnose left bundle branch block (LBBB). Little electrodes that detect the impulses that pass through the heart are carefully affixed to the skin of the arms, legs, and chest during this process. Doctors can then see the distinctive wide QRS complex and conduction anomalies that signify LBBB by using a computer to convert this activity into a visual tracing or image. Clinicians frequently conduct additional research once the ailment has been proven in order to rule out or find related issues. For instance, they might conduct a blood test to measure cholesterol levels and check blood pressure to check for hypertension or hypotension, both of which can lead to cardiovascular disease.
Furthermore, echocardiography and other imaging studies are commonly recommended to assess blood flow and pumping efficiency as well as to look at the anatomy of the heart. By observing the heart's reaction to stress, a nuclear cardiac stress test may also be suggested to screen for coronary artery disease. Furthermore, more specific information can be obtained using additional imaging methods including cardiac magnetic resonance imaging (MRI) and echocardiography. While cardiac MRI is particularly helpful for identifying fibrosis, scarring, and evaluating myocardial viability, echocardiography aids in determining whether mechanical dyssynchrony is present. Understanding the underlying aetiology of LBBB in elderly people and developing effective treatment plans can be greatly aided by MRI results.2,5
Treatments
Drug-based treatment
Drug-based therapy, which treats the underlying heart disease rather than the conduction problem itself, is the main method used to treat left bundle branch block (LBBB) in older people. The primary goal is to enhance overall cardiac function and slow the advancement of consequences like heart failure because LBBB frequently coexists with structural or functional heart issues. Physicians typically provide the standard guideline-directed medicinal therapy for heart failure to patients with decreased ejection fraction (HFrEF) and LBBB. This usually involves the use of angiotensin-converting enzyme (ACE) inhibitors, which help to relax blood vessels and lower afterload, mineralocorticoid receptor antagonists, which help to reduce fluid overload and prevent harmful cardiac remodelling, and beta-blockers, which slow down the heart rate and reduce myocardial oxygen demand.6
Careful titration of these medications is necessary since many older people have several comorbidities, such as diabetes, renal disease, or hypertension. The risk of side effects, which can include bradycardia, hypotension, electrolyte imbalances, or decreasing renal function, can be decreased by gradually adjusting dosages and keeping a careful eye on the patient. Drug therapy has been shown to improve heart failure outcomes, but it might not be sufficient to address the mechanical dyssynchrony brought on by LBBB. Even when a patient is receiving the best possible medication, the asynchronous contraction of the ventricles caused by the delay in electrical conduction can still reduce cardiac efficiency. Because of this, cardiac resynchronisation therapy (CRT) has emerged as a recognised and scientifically supported treatment option for a small number of patients who present with both LBBB and symptomatic heart failure. In order to re-establish coordinated contraction, CRT uses a specialised pacemaker to conduct biventricular pacing, which stimulates the left and right ventricles at the same time. This treatment has been demonstrated to alleviate heart failure symptoms, increase left ventricular ejection fraction, and reverse pathological remodelling of the heart muscle. Patients with LBBB-induced cardiomyopathy frequently benefit greatly from CRT, according to research by Jastrzebski et al., especially when more recent pacing techniques such left bundle branch area pacing (LBBAP) are used since they can more accurately repair conduction anomalies.4
In certain patient groups where the benefit is greatest, CRT is advised by the American College of Cardiology (ACC) and the European Society of Cardiology (ESC). These include people with heart failure who have a sinus rhythm, a QRS length of 150 ms or more, a reduced ejection fraction (LVEF ≤35%), and persistent symptoms after receiving the best medical care. They also have a characteristic LBBB morphology. Fulfilling these requirements indicates a greater chance of responding to CRT. The treatment is particularly beneficial for older patients since it not only increases the heart's pumping efficiency but also improves everyday functioning, lowers the number of hospitalisations, and ultimately raises quality of life.7
Summary
The diagnostic intricacy of left bundle branch block (LBBB) and its substantial correlation with underlying cardiovascular disease make it a unique clinical issue in the elderly. It is rare for LBBB to be an isolated discovery; instead, it typically indicates more extensive anatomical or functional problems in the heart. The electrocardiogram (ECG) must therefore be interpreted carefully and methodically in order to identify the conduction delay and accurately distinguish it from other intraventricular conduction abnormalities. A precise ECG diagnosis serves as the foundation for assessment, directing additional research and treatment choices.
Beyond the ECG, sophisticated imaging methods like cardiac magnetic resonance imaging (MRI) and echocardiography offer extra levels of information that are particularly helpful for elderly people. While cardiac MRI can detect fibrosis, scarring, or other structural alterations that could account for the conduction problem, echocardiography aids in evaluating left ventricular function, chamber enlargement, and the existence of mechanical dyssynchrony. By combining these techniques, physicians can assess the degree of dysfunction, gain a better understanding of myocardial viability, and determine whether LBBB is directly causing the patient's symptoms.
In older adults, where several comorbidities, including diabetes, hypertension, and coronary artery disease, often coexist, early diagnosis of LBBB is especially crucial, along with a thorough assessment of the patient's overall cardiovascular health. Early diagnosis allows for prompt therapies, whether supportive, pharmaceutical, or device-based, and can significantly lower long-term consequences. Clinicians are now more prepared than ever to approach LBBB precisely as diagnostic tools continue to develop and advanced imaging becomes more accessible in normal clinical practice. For elderly populations impacted by this conduction issue, this advancement holds the prospect of better patient outcomes, better management techniques, and ultimately an improved quality of life.
References
- Robert H. Whitaker, Anatomy of the heart,Medicine,Volume 46, Issue 8,2018,Pages 423-426,ISSN 1357-3039. https://doi.org/10.1016/j.mpmed.2018.05.010.
- Left bundle branch block: causes, symptoms & treatment. Cleveland Clinic. https://my.clevelandclinic.org/health/diseases/23287-left-bundle-branch-block [Accessed 29th September 2025].
- Angel L, Arsenescu Georgescu C. Left Bundle Branch Block in the Elderly: Particularities. Int Cardiovasc Res J. 2015;9(3):173-176. [Internet]. Available from: https://brieflands.com/articles/ircrj-11240.pdf [Accessed 29 September 2025].
- Ponnusamy, S. S., Vijayaraman, P., & Ellenbogen, K. A. (2024). Left Bundle Branch Block-associated Cardiomyopathy: A New Approach. Arrhythmia & electrophysiology review, 13, e15. https://doi.org/10.15420/aer.2024.14
- Kuetting, D. L., Sprinkart, A. M., Dabir, D., Schild, H. H., & Thomas, D. K. (2016). Assessment of cardiac dyssynchrony by cardiac MR: A comparison of velocity encoding and feature tracking analysis. Journal of magnetic resonance imaging : JMRI, 43(4), 940–946. https://doi.org/10.1002/jmri.25062
- McDonagh, T. A., Metra, M., Adamo, M., Gardner, R. S., Baumbach, A., Böhm, M., Burri, H., Butler, J., Čelutkienė, J., Chioncel, O., Cleland, J. G. F., Coats, A. J. S., Crespo-Leiro, M. G., Farmakis, D., Gilard, M., Heymans, S., Hoes, A. W., Jaarsma, T., Jankowska, E. A., Lainscak, M., … ESC Scientific Document Group (2021). 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. European heart journal, 42(36), 3599–3726. https://doi.org/10.1093/eurheartj/ehab368
- Glikson, M., Nielsen, J. C., Kronborg, M. B., Michowitz, Y., Auricchio, A., Barbash, I. M., Barrabés, J. A., Boriani, G., Braunschweig, F., Brignole, M., Burri, H., Coats, A. J. S., Deharo, J. C., Delgado, V., Diller, G. P., Israel, C. W., Keren, A., Knops, R. E., Kotecha, D., Leclercq, C., … ESC Scientific Document Group (2021). 2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy. European heart journal, 42(35), 3427–3520. https://doi.org/10.1093/eurheartj/ehab364

